Department of Biomedical, Surgical and Dental Sciences, Università degli Studi di Milano, Milan, Italy.
IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Clin Oral Investig. 2023 Apr;27(4):1311-1327. doi: 10.1007/s00784-023-04873-y. Epub 2023 Feb 28.
Periodontal disease and diabetes have an extensively investigated bidirectional correlation. Non-surgical periodontal treatment (NSPT) was proven to contribute to glycemic control. Moreover, it may benefit from the association of adjunctive therapies. The aim of the present systematic review is to assess the clinical efficacy of NSPT in association with laser (LT) or photodynamic therapy (PDT) in controlled or uncontrolled diabetic patients, and to grade the level of evidence.
Randomized controlled clinical trials with at least 3-month follow-up were searched in MEDLINE via OVID, EMBASE, and Cochrane Central, screened for inclusion, and grouped based on the performed treatments, follow-up time, type of diabetes, and level of glycemic control.
Eleven RCTs with 504 total subjects were included. The adjunct of PDT showed a statistically significant 6-month difference in PD changes (with low certainty of evidence), but not in CAL changes, while a significant difference in 3-month PD and CAL changes was found with the adjunct of LT (low certainty of evidence). Patients treated with PDT registered a higher decrease in HbA1c levels at 3 months, but no significant difference was noted at 6 months; LT also led to better HbA1c changes at 3 months with a moderate certainty of evidence.
Despite the promising short-term HbA1c decrease, the results should be interpreted with caution due to the small effect sizes and the statistical heterogeneity, and further evidence from well-designed RCTs is needed to support the routine use of PDT or LT in adjunct to NSPT.
牙周病和糖尿病之间存在广泛研究的双向关联。牙周非手术治疗(NSPT)已被证明有助于血糖控制。此外,它可能受益于辅助治疗的联合应用。本系统评价的目的是评估 NSPT 联合激光(LT)或光动力疗法(PDT)在控制或未控制的糖尿病患者中的临床疗效,并对证据水平进行分级。
通过 OVID、EMBASE 和 Cochrane Central 在 MEDLINE 中搜索至少有 3 个月随访的随机对照临床试验,进行纳入筛选,并根据所进行的治疗、随访时间、糖尿病类型和血糖控制水平进行分组。
共纳入 11 项 RCT,总计 504 名受试者。PDT 的辅助治疗在 6 个月时 PD 变化方面具有统计学显著差异(证据确定性低),但在 CAL 变化方面没有差异,而 LT 的辅助治疗在 3 个月和 6 个月时 PD 和 CAL 变化均有显著差异(证据确定性低)。接受 PDT 治疗的患者在 3 个月时 HbA1c 水平下降幅度更大,但在 6 个月时无显著差异;LT 也能更好地降低 3 个月时的 HbA1c 值,具有中等确定性的证据。
尽管短期 HbA1c 下降有希望,但由于效应量较小且存在统计学异质性,结果应谨慎解释,需要更多来自精心设计的 RCT 的证据来支持 PDT 或 LT 联合 NSPT 的常规应用。